<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ma Y</submitter><funding>Natural Science Foundation of Bengbu Medical College</funding><funding>This study was supported by Anhui University Natural Science Research Project</funding><pagination>54</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9938568</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Invasion and metastasis of hepatocellular carcinoma (HCC) is still an important reason for poor prognosis. LincRNA ZNF529-AS1 is a recently identified tumour-associated molecule that is differentially expressed in a variety of tumours, but its role in HCC is still unclear. This study investigated the expression and function of ZNF529-AS1 in HCC and explored the prognostic significance of ZNF529-AS1 in HCC.&lt;h4>Methods&lt;/h4>Based on HCC information in TCGA and other databases, the relationship between the expression of ZNF529-AS1 and clinicopathological characteristics of HCC was analysed by the Wilcoxon signed-rank test and logistic regression. The relationship between ZNF529-AS1 and HCC prognosis was evaluated by Kaplan‒Meier and Cox regression analyses. The cellular func</pubmed_abstract><journal>BMC bioinformatics</journal><pubmed_title>LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients.</pubmed_title><pmcid>PMC9938568</pmcid><funding_grant_id>2020byzd105</funding_grant_id><funding_grant_id>KJ2021A0731</funding_grant_id><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Ma SS</pubmed_authors><pubmed_authors>Lu Z</pubmed_authors><pubmed_authors>Zhao G</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Sun WL</pubmed_authors></additional><is_claimable>false</is_claimable><name>LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients.</name><description>&lt;h4>Background&lt;/h4>Invasion and metastasis of hepatocellular carcinoma (HCC) is still an important reason for poor prognosis. LincRNA ZNF529-AS1 is a recently identified tumour-associated molecule that is differentially expressed in a variety of tumours, but its role in HCC is still unclear. This study investigated the expression and function of ZNF529-AS1 in HCC and explored the prognostic significance of ZNF529-AS1 in HCC.&lt;h4>Methods&lt;/h4>Based on HCC information in TCGA and other databases, the relationship between the expression of ZNF529-AS1 and clinicopathological characteristics of HCC was analysed by the Wilcoxon signed-rank test and logistic regression. The relationship between ZNF529-AS1 and HCC prognosis was evaluated by Kaplan‒Meier and Cox regression analyses. The cellular func</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T20:09:34.708Z</modification><creation>2025-02-19T02:57:04.858Z</creation></dates><accession>S-EPMC9938568</accession><cross_references><pubmed>36803542</pubmed><doi>10.1186/s12859-023-05189-0</doi></cross_references></HashMap>